Shifting Supply Chain To Asia Will Require More Quality Control Vigilance - World Pharma Manufacturing Summit
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - As Big Pharma continues to shift API manufacturing and contract manufacturing to Asia, it must be vigilant in verifying quality even as regulatory agencies in the region enact more stringent guidelines, according to speakers at the World Pharma Manufacturing Summit in Shanghai
You may also be interested in...
Transitioning Public Health To Non-communicable Diseases In Emerging Markets Highlights Supply Chain Gaps
When looking for ways to care for chronic diabetes and hypertension patients, Cambodia looked to its experiences dealing with HIV/AIDS.
UPS Picks Up Cold Chain Market Share In APAC To Meet Region's Higher Import, Export Needs
SINGAPORE - United Parcel Services Singapore Pte Ltd is developing its footprint in the Asian healthcare sector, offering its global cargo services as demand builds for cold chain management in the region
UPS Picks Up Cold Chain Market Share In APAC To Meet Region's Higher Import, Export Needs
SINGAPORE - United Parcel Services Singapore Pte Ltd is developing its footprint in the Asian healthcare sector, offering its global cargo services as demand builds for cold chain management in the region